An analysis found that out of 1,357 AI-enabled medical devices cleared by the FDA, only three were actually tested for their effect on patient health outcomes.
Key Details
- 11,357 FDA-cleared AI medical devices were analyzed.
- 2Only 34 devices had associated registered clinical trials.
- 3Just 3 devices were tested for patient-centered outcomes like survival or quality of life.
- 4Most studies excluded groups like pregnant women, older adults, and non-English speakers.
- 5Current FDA clearance requires 'substantial equivalence,' not proven patient benefit.
- 6Authors propose new frameworks for requiring outcome-based evidence across diverse populations.
Why It Matters
Most AI devices, including those used in imaging and diagnostic support, are authorized without proof that they improve real-world patient outcomes. This policy gap is significant for radiology, as clinical validation is crucial for responsible AI deployment and patient safety.
Source
EurekAlert
Related News
•EurekAlert
TRUECAM AI Framework Boosts Reliability in Cancer Pathology Imaging
PolyU researchers introduce the TRUECAM AI framework to enhance the trustworthiness of pathology AI for cancer diagnosis.
•EurekAlert
Deep Learning Shows Superior Sensitivity in Sinus Disease CT Changes
Automated deep learning achieves greater sensitivity in detecting treatment-related changes in chronic sinus disease on CT scans than standard visual scoring.
•EurekAlert
Mayo Clinic's AI Advances Ultrasound Detection of Heart Obstruction
Mayo Clinic researchers have developed an AI model that detects heart obstructions from routine ultrasound, potentially improving early identification of at-risk patients.